FDA Approves Wegovy to Treat Serious Liver Disease

New drug could treat serious fatty liver disease

knowridge.com - 19/Sep 10:31

Researchers at University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating...

New drug could treat serious fatty liver disease

knowridge.com - 19/Sep 10:31

Researchers at University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating...

FDA Approves New Therapy for Advanced Breast Cancer

wn.com - 26/Sep 14:58

The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...

FDA Approves New Therapy for Advanced Breast Cancer

wn.com - 26/Sep 14:58

The Food and Drug Administration on Sept. 25 approved a new therapy for advanced breast cancer, based on data from a phase...

FDA Grants Accelerated Approval for First Treatment for Barth Syndrome, Forzinity

drugs.com - 25/Sep 17:09

THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...

FDA Grants Accelerated Approval for First Treatment for Barth Syndrome

drugs.com - 25/Sep 17:44

THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...

FDA Grants Accelerated Approval for First Treatment for Barth Syndrome

drugs.com - 25/Sep 17:44

THURSDAY, Sept. 25, 2025 -- The U.S. Food and Drug Administration granted accelerated approval to Forzinity (elamipretide) injection as the first...

FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

drugs.com - 24/Sep 21:09

WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...

FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

drugs.com - 24/Sep 21:09

WEDNESDAY, Sept. 24, 2025 -- The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the...

Orange B Food Dye May Soon Be Removed From U.S. Market, FDA Says

drugs.com - 18/Sep 14:09

THURSDAY, Sept. 18, 2025 — Federal health officials want to take Orange B — an artificial food dye that hasn’t been used in more...

Rubriques :

FDA Approves Wegovy to Treat Serious Liver Disease

Articles similaires

New drug could treat serious fatty liver disease

New drug could treat serious fatty liver disease

FDA Approves New Therapy for Advanced Breast Cancer

FDA Approves New Therapy for Advanced Breast Cancer

FDA Grants Accelerated Approval for First Treatment for Barth Syndrome, Forzinity

FDA Grants Accelerated Approval for First Treatment for Barth Syndrome

FDA Grants Accelerated Approval for First Treatment for Barth Syndrome

FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

FDA Approves Subcutaneous Tremfya Induction Treatment for Ulcerative Colitis

Orange B Food Dye May Soon Be Removed From U.S. Market, FDA Says

Les derniers communiqués